0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector

RxCUI: 2706644
RxNorm name: 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector
Display name: 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector
Full name: 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761299	Simlandi	adalimumab-ryvk	351(k) Interchangeable	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Adalimumab-ryvk	ADALIMUMAB-RYVK	Teva Pharmaceuticals USA, Inc.	f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6	2026-03-03	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2706644
Adalimumab-ryvk	ADALIMUMAB-RYVK	Teva Pharmaceuticals USA, Inc.	2d19a877-1f5a-4731-800a-dddadc424080	2025-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2706644
Simlandi	ADALIMUMAB-RYVK	Teva Pharmaceuticals USA, Inc.	12f609c9-2088-bb05-e063-6394a90a9ecc	2025-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2706644

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
12f609c9-2088-bb05-e063-6394a90a9ecc	0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector	SCD	24	These highlights do not include all the information needed to use SIMLANDI safely and effectively. See full prescribing information for SIMLANDI. SIMLANDI ® (adalimumab-ryvk) injection, for subcutaneous use Initial U.S. Approval: 2024 SIMLANDI (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222
12f609c9-2088-bb05-e063-6394a90a9ecc	adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector	SY	24	These highlights do not include all the information needed to use SIMLANDI safely and effectively. See full prescribing information for SIMLANDI. SIMLANDI ® (adalimumab-ryvk) injection, for subcutaneous use Initial U.S. Approval: 2024 SIMLANDI (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222
12f609c9-2088-bb05-e063-6394a90a9ecc	adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector	PSN	24	These highlights do not include all the information needed to use SIMLANDI safely and effectively. See full prescribing information for SIMLANDI. SIMLANDI ® (adalimumab-ryvk) injection, for subcutaneous use Initial U.S. Approval: 2024 SIMLANDI (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222
2d19a877-1f5a-4731-800a-dddadc424080	adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector	SY	7	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20251231
2d19a877-1f5a-4731-800a-dddadc424080	0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector	SCD	7	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20251231
2d19a877-1f5a-4731-800a-dddadc424080	adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector	PSN	7	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20251231
f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6	adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector	PSN	1	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20260303
f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6	adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector	SY	1	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20260303
f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6	0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector	SCD	1	These highlights do not include all the information needed to use ADALIMUMAB-RYVK safely and effectively. See full prescribing information for ADALIMUMAB-RYVK . ADALIMUMAB-RYVK injection, for subcutaneous use Initial U.S. Approval: 2024 This product is SIMLANDI ® (adalimumab-ryvk). SIMLANDI ® (adalimumab-ryvk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and th	20260303